the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

View All Categories

Neurodegenerative Disease Market Research

 

Global Information, Inc. offers market intelligence on every topic in the Neurodegenerative Disease market, including, but not limited to: Neuropathic Pain; Alzheimer's Disease; CNS Disorders; Neurodegenerative Disorders; Parkinson's Disease.

We offer market research and business analysis in the Neurodegenerative Disease market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, developments, and projections. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 

Reports

Central Nervous System Alzheimer Disease
Published : 2008/03
Life Science Analytics' , Central Nervous System Alzheimer Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the late ...

Central Nervous System Anxiety
Published : 2008/03
Life Science Analytics' , Central Nervous System Anxiety contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news an ...

Central Nervous System Attention Deficit Disorder with Hyperactivity
Published : 2008/03
Life Science Analytics' , Central Nervous System Attention Deficit Disorder with Hyperactivity contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as w ...

Central Nervous System Dementia
Published : 2008/03
Life Science Analytics' , Central Nervous System Dementia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ...

Central Nervous System Depression
Published : 2008/03
Life Science Analytics' , Central Nervous System Depression contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news ...

Central Nervous System Epilepsy
Published : 2008/03
Life Science Analytics' , Central Nervous System Epilepsy contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ...

Central Nervous System Headache
Published : 2008/03
Life Science Analytics' , Central Nervous System Headache contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ...

Central Nervous System Insomnia or Sleep Disorders
Published : 2008/03
Life Science Analytics' , Central Nervous System Insomnia or Sleep Disorders contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary o ...

Central Nervous System Memory Impairment
Published : 2008/03
Life Science Analytics' , Central Nervous System Memory Impairment contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the late ...

Central Nervous System Migraine
Published : 2008/03
Life Science Analytics' , Central Nervous System Migraine contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ...

Central Nervous System Multiple Sclerosis
Published : 2008/03
Life Science Analytics' , Central Nervous System Multiple Sclerosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the lat ...

Central Nervous System Neuropathy
Published : 2008/03
Life Science Analytics' , Central Nervous System Neuropathy contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news ...

Central Nervous System Pain
Published : 2008/03
Life Science Analytics' , Central Nervous System Pain contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and d ...

Central Nervous System Parkinson Disease
Published : 2008/03
Life Science Analytics' , Central Nervous System Parkinson Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the late ...

Central Nervous System Psychotic Disorders
Published : 2008/03
Life Science Analytics' , Central Nervous System Psychotic Disorders contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the la ...

Central Nervous System Schizophrenia
Published : 2008/03
Life Science Analytics' , Central Nervous System Schizophrenia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest n ...

Central Nervous System Seizures
Published : 2008/03
Life Science Analytics' , Central Nervous System Seizures contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news a ...

Central Nervous System Stroke
Published : 2008/03
Life Science Analytics' , Central Nervous System Stroke contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and ...

Parkinson's Disease Market analysis and forecasts, 2008-2012, 2017 & 2022
Published : 2008/01
The report analysis PD sales over the next 15 years and delivers the percentage market growth. The projected revenue growth will be driven largely by reformulations that will decrease the burden of polypharmacy in patients receiving PD pharmacotherapy. ...

Peripheral Neuropathy and Neuropathic Pain, 2008
Published : 2008/01
This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally. PN and NP are causally linked to a number of diseases, however diabetes, cancer and HIV alone are expected to increase the prev ...

U.S. Neurostimulation Devices Market
Published : 2008/01
This research service analyzes the U.S. neurostimulation market from 2003 to 2013. ...

Pipeline Insight: Orphan Diseases in CNS - Part II: Amyotrophic Lateral Sclerosis
Published : 2007/12
This report provides Orphan Diseases Pipeline Insight Market Research, Trends, Analysis. ...

Stakeholder Insight: Parkinson's Disease - Evidence of neuroprotection essential to progress treatment dynamics
Published : 2007/12
This report provides Parkinson's Disease Stakeholder Insight Market Research, Trends, Analysis. ...

Cell-Based Diagnostics: Technology, Applications, and Markets, 2nd Edition
Published : 2007/11
This report covers assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood, bone marrow, urine, cerebrospinal and other body fluids and tissue samples. ...

Nicotinic Receptor Agonists for Treating Diseases of Cognitive Dysfunction
Published : 2007/11
Nicotine has long been known to improve cognitive function, but its adverse effects make it problematic as a treatment for diseases of cognitive dysfunction. Recent research has revealed that certain subtypes of nicotinic acetylcholinesterase receptors (n ...

The Anti-Migraine Market 2007-2022
Published : 2007/11
The report provides in-depth market analysis upon these areas, and extensively identifies both prescription and OTC drugs. The report also focuses on the technological issues, including the latest trends, patents, new products and other influential factor ...

Brand Positioning: Cell Biology Kits & Reagents
Published : 2007/10
This report provides Cell Biology Kits & Reagents Market Research, Trends, Analysis. ...

Commercial Insight: Epilepsy - Companies committed to the cause will reap the benefits
Published : 2007/09
This report provides Epilepsy Commercial Insight Market Research, Trends, Analysis. ...

Commercial Insight: Migraine - Opportunities will exist in the wake of generic attack
Published : 2007/09
This report provides Migraine Commercial Insight Market Research, Trends, Analysis. ...

Pipeline and Commercial Insight: Parkinson's Disease - Market to grow as first round of lifecycle management strategies succeed
Published : 2007/09
The PD market is set to continue to grow over the next 7 years, reaching over $2.37 billion in 2013, a 39% increase from 2006 levels. Combinations, reformulations, and indication expansions will drive the majority of this growth, with key brands expected ...

Pipeline Insight: Neuropathic Pain - Emerging drugs fail to capitalize in lucrative market
Published : 2007/09
The neuropathic pain market is forecast to double from 2006 to reach over $7 billion by 2016. At this time, the current late-stage neuropathic pain pipeline is forecast to take only 18% of the total market share, highlighting an opportunity for better pip ...

Does the Treatment of Huntington's Disease Represent a Commercial Opportunity?
Published : 2007/08
Huntington' s disease (HD) is a genetic neurological disorder characterized by uncontrolled body movements and cognitive dysfunction. No drugs are approved to treat the disorder, leaving a high level of unmet need. ...

Competitor Insights for Interventional Cardiology Devices 2007
Published : 2007/07
In 2006, the global interventional cardiology device market-including revenues generated in the US, Europe (France, Germany, Italy, and the UK), and Japan-was valued at over $6.0 billion. ...

Advances in Neurostimulators
Published : 2007/06
This research service analyses the critical trends and advancements made in neurostimulators. ...

US Markets for Varicose Vein Treatment Devices 2007
Published : 2007/06
This market consists of endovenous laser ablation, endovenous radio frequency ablation, surgical stripping, phlebectomy, and sclerotherapy procedures for varicose veins ...

Pipeline Insight: Epilepsy - Pipeline drugs struggle to outshine their marketed predecessors
Published : 2006/10
This report provides the research about Epilepsy Pipeline Insight Market. ...

Pipeline Insight: Parkinson's Disease and Restless Legs Syndrome - Reformulations set to drive near-term growth
Published : 2006/08
Despite affecting a large number of individuals, there are currently no treatments capable of curing either Parkinson's disease or Restless Legs Syndrome. ...

Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes and COPD
Published : 2006/06
Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD is a survey of emerging targets in these important diseases. ...

New Drug Futures: Central Nervous System
Published : 2006/05
This chapter of New Drug Futures evaluates, compares and contrasts the prospects for the compounds that will revolutionise the pharmaceutical industry over the next 5 years and beyond in the CNS sector. ...

Partneringdesk Deals and alliances in central nervous system diseases
Published : 2006/04
Partneringdesk deals and alliances in central nervous system diseases provides an in-depth view of over 1100 deals and alliances announced in central nervous system diseases between 2001 and 2006 ...

A Survey of Private Companies Active in Alzheimer's Drug R&D
Published : 2006/03
This spin-off report of A Survey of Private Companies Active in CNS & PNS Drug R&D comprises the private companies active in Alzheimer's R&D covered in the full report. ...

A Survey of Private Companies Active in CNS & PNS Drug R&D
Published : 2006/03
Launched end of March 2006 this product combines an Excel company database covering 209 private companies active in CNS & PNS drug research and development with a full cross-referenced report in PDF format describing each company in detail. ...

Japanese Markets for Interventional Neuroradiology Devices 2006
Published : 2005/12
In 2005, this market was valued at $36.6 million and will increase at a compound annual growth rate of 15.3% over the next five years. ...

Pipeline and Commercial Insight: Alzheimer's Disease - Beta treatments on the horizon
Published : 2005/11
Alzheimers patients remain poorly treated and are growing in number. Currently, cholinesterase inhibitors and the more recent NMDA-receptor antagonists provide only moderate and temporary symptomatic benefit. By the end of the decade ...

The World Market for Neurotherapeutic Drugs
Published : 2005/09
The report covers both currently marketed and late-stage development neurotherapeutic products in detail. Revenues for each segment were generated using dollar and unit sales for each product. ...

Tysabri - Can Efficacy of VLA-4 Mechanism Overcome Safety Concerns?
Published : 2005/08
Rapid uptake of products focused on drug-resistant infections, such as Pfizer's Zyvox (linezolid), has been driven by the increasing numbers of immunocompromised patients in hospitals. ...

CNS Drug Discoveries : what the future holds (Pain)
Published : 2005/06
Pain products generated global sales of nearly US$40 billion in 2003 (including anaesthetics and antimigraine agents) and this is expected to double by 2010. ...

Global Markets for Alzheimer's Disease Medications 2005
Published : 2005/04
This report provides the research about Global Alzheimer's Disease Medications Market. ...

Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches
Published : 2005/03
CNS disorders affect a vast patient population and represent a huge area of unmet therapeutic need. In the United States alone, Alzheimerfs disease (AD), Parkinsonfs disease (PD), and amyotrophic lateral sclerosis (ALS) afflict more than 6.5 million peo ...

World Neurodegeneratives Disease Markets, 2005-2009
Published : 2005/02
All the answers to these questions and other aspects of this $8bn market are to be found in visiongains World Neurodegeneratives Disease Markets, 2005-2009. ...

Newsletters

Neuro Drug Focus (NDF)
Issues / Year : 12
Neuro Drug Focus (NDF) is a new business news service that will keep you fully updated with the latest developments in neurodegenerative product registration, agreements and clinical trials. ...


Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.